首页|miR-145、miR-186表达与非小细胞肺癌组织临床病理特征和PI3K/Akt/mTOR信号通路的关系

miR-145、miR-186表达与非小细胞肺癌组织临床病理特征和PI3K/Akt/mTOR信号通路的关系

扫码查看
目的:探讨微小核糖核酸(miR)-145、miR-186表达与非小细胞肺癌(NSCLC)临床病理特征和磷脂酰肌醇3-激酶(PI3K)/蛋白激酶B(Akt)/哺乳动物雷帕霉素靶蛋白(mTOR)信号通路的关系.方法:选择2020年3月至2023年3月我院收治的128例行肺癌根治手术治疗的NSCLC患者,取其术中癌组织和癌旁组织(距离癌组织5 cm以上),采用实时荧光定量聚合酶链式反应(qRT-PCR)检测 miR-145、miR-186 以及 PI3K mRNA、Akt mRNA、mTOR mRNA 表达.分析 miR-145、miR-186 表达与 NSCLC 患者临床病理特征的关系;Pearson检验分析NSCLC患者癌组织miR-145、miR-186表达与PI3K mRNA、Akt mRNA、mTORmRNA表达的相关性.结果:癌组织miR-145、miR-186表达低于癌旁组织(P<0.05),低分化、TNM ⅢA期、淋巴结转移的NSCLC组织miR-145、miR-186表达低于中高分化、TNM Ⅰ~Ⅱ期、未发生淋巴结转移的NSCLC组织(P<0.05).癌组织PI3KmRNA、Akt mRNA、mTORmRNA 表达均高于癌旁组织(P<0.05),癌组织 miR-145、miR-186 表达与 PI3K mRNA、Akt mRNA、mTORmRNA表达均呈负相关(P<0.05).结论:NSCLC组织中miR-145、miR-186表达下调,miR-145、miR-186表达下调可能激活PI3K/Akt/mTOR信号通路促使NSCLC进展,且与NSCLC患者癌组织低分化、TNM ⅢA期、淋巴结转移有关.
Relationship between the Expression of miR-145 and miR-186 and Clinical Pathological Characteristics and PI3K/Akt/mTOR Signaling Pathway in Non-Small Cell Lung Cancer Tissues
Objective:To investigate the relationship between the expression of micro ribonucleic acid(miRNA)-145,miR-186 and clinical pathological characteristics and phosphatidylinositol 3-kinase(PI3K)/protein kinase B(Akt)/mammalian target of rapamycin(mTOR)signaling pathway in non-small cell lung cancer(NSCLC)tissues.Methods:128 NSCLC patients who underwent radical surgery for lung cancer in our hospital From March 2020 to March 2023 were selected,the intraoperative cancer tissues and cancer adja-cent tissues(more than 5cm from the cancer tissues)were taken,the expression of miR-145,miR-186,PI3K mRNA,Akt mRNA and mTOR mRNA was detected by real-time fluorescence quantitative polymerase chain reaction(qRT-PCR).The relationship between the expression of miR-145 and miR-186 and the clinical pathological characteristics of NSCLC patients was analyzed.The correlation between the expression of miR-145,miR-186 and the expression of PI3K mRNA,Akt mRNA and mTOR mRNA in NSCLC patients were analyzed by Pearson test.Results:The expression of miR-145 and miR-186 in cancer tissues was lower than that in cancer adjacent tissues(P<0.05),the expression of miR-145 and miR-186 in NSCLC tissues with low differentiation,TNM ⅢA stage and lymph node metastasis was lower than that in NSCLC tissues with medium to high differentiation,TNM Ⅰ~Ⅱ stage and without lymph node metasta-sis(P<0.05).The expression of PI3K mRNA,Akt mRNA and mTOR mRNA in cancer tissues was higher than that in cancer adjacent tis-sues(P<0.05),the expression of miR-145 and miR-186 in cancer tissues was negatively correlated with the expression of PI3K mRNA,Akt mRNA and mTOR mRNA(P<0.05).Conclusion:The expression of miR-145 and miR-186 in NSCLC tissues is down-regulate,the down-regulate of miR-145 and miR-186 expression may activate the PI3K/Akt/mTOR signaling pathway to promote the progression of NSCLC,and is associate with poor differentiation of cancer tissue,TNM ⅢA stage and lymph node metastasis in NSCLC patients.

Non-small cell lung cancerMicro ribonucleic acid-145Micro ribonucleic acid-186PI3K/Akt/mTOR signaling path-wayPathological characteristics

隋倩、胡海舰、刘洁琼、刘冀衡、曹永清

展开 >

长沙市第一医院血液肿瘤科 湖南长沙 410005

非小细胞肺癌 微小核糖核酸-145 微小核糖核酸-186 PI3K/Akt/mTOR信号通路 病理特征

湖南省卫健委科研计划项目

202303016809

2024

现代生物医学进展
黑龙江省森工总医院 哈尔滨医科大学附属第四医院

现代生物医学进展

CSTPCD
影响因子:0.755
ISSN:1673-6273
年,卷(期):2024.24(4)
  • 28